Ultrafast Forensic Screen for Amphetamines in Urine Using the Agilent RapidFire High-Throughput Mass Spectrometry System

Significance of the Topic

Forensic toxicology demands rapid, sensitive, and high-throughput screening of amphetamine-class drugs in urine to support legal and clinical decision-making. Traditional immunoassays followed by chromatographic confirmation can be time-consuming and prone to cross-reactivity with structurally related compounds.

Objectives and Study Overview

This work presents the development and validation of an ultrafast screening method for five amphetamines (amphetamine, methamphetamine, 3,4-methylenedioxyamphetamine, 3,4-methylenedioxy-N-methylamphetamine, and 3,4-methylenedioxyethylamphetamine) in human urine. Key goals included maximizing throughput, ensuring analytical specificity, and achieving robust quantitative performance.

Methodology

Drug-free human urine was spiked with known concentrations of each analyte and corresponding isotopically labeled internal standards. Samples were diluted 1:50 with aqueous solution containing internal standards and transferred to a reversed-phase C18 SPE cartridge. Analytes were eluted directly into an Agilent 6460 triple quadrupole mass spectrometer operating in multiple reaction monitoring mode. Calibration curves spanned 25–5000 ng/mL with 1/x weighting.

Instrumentation Used

• Agilent RapidFire 360 high-throughput SPE system
• Agilent 6460 Triple Quadrupole Mass Spectrometer
• Agilent MassHunter Qualitative and Quantitative Analysis software (B.05.00)

Main Results and Discussion

All five analytes exhibited excellent linearity (R² > 0.998). Limits of detection and quantification were 25 ng/mL and 50 ng/mL, respectively. Intra- and inter-day precision (CV) remained below 10 % and accuracy within ±15 % across low, medium, and high QC levels. No interference was observed when samples were co-spiked with 100,000 ng/mL of common confounders (phentermine, ephedrine, pseudoephedrine, phenylpropanolamine). The method achieved a cycle time of 14.5 seconds per sample, enabling throughput above 240 samples/hour. Cartridge performance remained stable over 2000 consecutive injections with no loss of sensitivity or peak integrity.

Benefits and Practical Applications

• Rapid analysis reduces turnaround time compared to conventional LC–MS or GC–MS workflows
• High analytical specificity minimizes false positives from over-the-counter analogs
• Robust quantitative performance supports large-scale forensic and clinical screening
• Minimal manual preparation and integration into automated platforms improve laboratory efficiency

Future Trends and Opportunities

Further integration of ultrafast SPE–MS/MS platforms with laboratory information management systems can enable near real-time reporting. Expansion of analyte panels to include novel psychoactive substances and application of high-resolution mass spectrometry will address evolving forensic and clinical needs. Advances in data analytics and machine learning may enhance compound identification and streamline decision support.

Conclusion

The Agilent RapidFire SPE–MS/MS method delivers a validated, high-throughput screening solution for five amphetamine drugs in urine, combining speed, sensitivity, specificity, and reproducibility. It represents an effective alternative to traditional immunoassay and chromatographic approaches in high-volume forensic and clinical laboratories.

References

1. Stout PR, Klette KL, Horn CK. Evaluation of ephedrine, pseudoephedrine and phenylpropanolamine concentrations in human urine and comparison of immunoassays. J Forensic Sci. 2004;49:160–164.
2. Substance Abuse and Mental Health Services Administration. Manual for Urine Laboratories, National Laboratory Certification Program. U.S. Department of Health and Human Services; 2010.
3. Moorman P, Hughes J. Amphetamines (Expanded) in Urine by Liquid Chromatography/Triple Quadrupole Mass Spectrometry (LC/MS/MS). Agilent Technologies; Publication 5990-5865EN; 2014.